1 December 2023
Embracing the theme ‘Let communities lead’ on World AIDS Day 2023, the Medicines Patent Pool amplifies the resilient voices of individuals in India, Kenya, Senegal, and South Africa—testimonies of courage, resilience, and the profound impact of community-led initiatives in the HIV response. As we delve into the heart of these communities, we unveil narratives of triumph over sickness, battles for treatment, encounters with stigma, and the invaluable strength derived from mutual support.
Through our commitment to voluntary licensing, we’ve empowered over 130 low- and middle-income countries with quality, affordable HIV treatments. Today, millions of lives are touched by the efficacy of generic medicines, a testament to the strength of collaboration and the enduring bond with the communities we serve. In the spirit of gratitude, we celebrate our partners and express heartfelt appreciation to the communities that stand with us, marking each step toward a healthier, more inclusive future.
Click here to discover their stories…
Press and Media
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.
MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada, the World Intellectual Property Organization (WIPO) and the Government of Flanders. MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.